The Trump administration is closing a loophole that drugmakers could use to avoid negotiations when they add active ingredients to drugs. It's also codifying regulations.
Companies are being too conservative in how they interpret FDA's AI guidance, but the agency can do more to help, too, Tala ...
The newly cleared device is based around an app that helps a patient manage their diabetes using a treatment plan defined by ...
Posts claimed federal officials "upgraded" the recall to the highest level, meaning there's a "reasonable probability of ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
The US Food and Drug Administration (FDA) has revised a 2023 draft guidance on master protocols for drug and biological ...
Sworn Declarations from Former FDA Counsel and Renowned Device Regulation Expert Expose Clear Regulatory Carve-Outs for Outpatient Clinics; Emergency Motion Seeks to Strike Verdict Before July 7 ...
June 22 (Reuters) - The U.S. Food and Drug Administration said on Monday it is launching a series of measures to speed up ...
It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local ...
On June 18, 2026, the Food and Drug Administration (“FDA”) announced the submission of a proposed collection of information ...
The U.S. Food and Drug Administration (FDA) has announced the food supply issues it seeks to tackle by year's end.